The Registrational Clinical Data of Glecirasib was Published in Nature Medicine

The Registrational Clinical Data of Glecirasib was Published in Nature Medicine

BEIJING, SHANGHAI and BOSTON, Jan. 7, 2025 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets announced today that the data from a registrational clinical trial of its independently developed...

Innovent Announces Second New Drug Application of DOVBLERON ® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) was Approved by China's National Medical Products Administration

Innovent Announces Second New Drug Application of DOVBLERON ® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) was Approved by China's National Medical Products Administration

SAN FRANCISCO and SUZHOU, China, Jan. 3, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of...

VIVOTEK Wins Double Honors for Its Commitment to Sustainability

VIVOTEK Wins Double Honors for Its Commitment to Sustainability

TAIPEI, Dec. 26, 2024 /PRNewswire/ -- VIVOTEK (3454-TW), the global leading security solution provider, has once again demonstrated its outstanding commitment to sustainability. Participating for the first time in the 17th Taiwan Corporate...

Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Preclinical Model

Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Preclinical Model

In a head-to-head diet-induced obese (DIO) mouse study, ASC47 low dose combination 1 (ASC47, 3 mg/kg, subcutaneous ( SQ ) , once every four weeks plus semaglutide, 30 nmol/kg, SQ, once daily) , demonstrated superior weight loss compared to...

Fashion Icon Liu Wen Radiates Brilliance at Madame Tussauds Hong Kong Unveiling Event

Fashion Icon Liu Wen Radiates Brilliance at Madame Tussauds Hong Kong Unveiling Event

HONG KONG, Dec. 17, 2024 /PRNewswire/ -- Madame Tussauds Hong Kong, a brand under the Merlin Entertainment Group, proudly unveils the latest wax figure of internationally acclaimed model, Liu Wen. Visiting Madame Tussauds Hong Kong, Liu Wen...

MoonFox Analysis | From Significant Growth to Rational Cooling: The Study Tour Market Enters a Transitional Phase

MoonFox Analysis | From Significant Growth to Rational Cooling: The Study Tour Market Enters a Transitional Phase

About us: Aurora Mobile (NASDAQ: JG) established in 2011, is a leading customer engagement and marketing technology service provider in China. Its business includes notification services, marketing growth, development tools, and data products. As...

Hisense Scores Record-Breaking Black Friday Sales Abroad with Surge in Large Screen TV and Smart Home Innovation

Hisense Scores Record-Breaking Black Friday Sales Abroad with Surge in Large Screen TV and Smart Home Innovation

QINGDAO, China, Dec. 16, 2024 /PRNewswire/ -- Hisense, a leading brand in global consumer electronics and home appliances, demonstrated its global leadership in consumer electronics with record-breaking sales during the Black Friday period. The...

Accropeutics Inc. Announces U.S. FDA Clearance of IND Application for RIPK2 Inhibitor AC-101

Accropeutics Inc. Announces U.S. FDA Clearance of IND Application for RIPK2 Inhibitor AC-101

Company to conduct a Phase II multi-regional clinical trial (MRCT) for the treatment of Ulcerative Colitis (UC) A Phase Ib Study of AC-101 for Ulcerative Colitis (UC) has been initiated in China AC-101 demonstrated a favorable safety and PK/PD...

Most Impactful Marketing Campaigns in 2024 Across APAC Celebrated at Prestigious MMA SMARTIES APAC 2024

Most Impactful Marketing Campaigns in 2024 Across APAC Celebrated at Prestigious MMA SMARTIES APAC 2024

SINGAPORE, Dec. 13, 2024 /PRNewswire/ -- The MMA SMARTIES APAC 2024 Awards honored an impressive 93 winning campaigns, presenting 37 Gold, 24 Silver, and 32 Bronze medals, along with 11 industry winners that showcased the best of what APAC has to...

2024 SABCS|Results Unveiled for the Phase III Study of Disitamab Vedotin in Treating HER2-Positive Advanced Breast Cancer with Liver Metastasis

2024 SABCS|Results Unveiled for the Phase III Study of Disitamab Vedotin in Treating HER2-Positive Advanced Breast Cancer with Liver Metastasis

YANTAI, China, Dec. 13, 2024 /PRNewswire/ -- On the morning of December 12, 2024 (UTC-6), at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San Antonio Breast Cancer Symposium (SABCS), RemeGen Co. Ltd. ("RemeGen") (9995.HK,...

  • 1
  • 2
  • 3
  • menu
    menu